Search - tctmd.com

Displaying 1 - 20 of 124

Sort: Relevancy | Date

News Conference News AHA 2025

Stress CMR Facilitates Diagnosis, Targeted Care in ANOCA: CorCMR

Caitlin E. Cox

November 14, 2025

News Conference News TCT 2025

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Michael O'Riordan

October 28, 2025

$Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis$

News Daily News

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

Todd Neale

August 13, 2025

News Conference News EuroPCR 2025

Early Coronary Function Testing Improves Quality of Life in ANOCA

Yael L. Maxwell

May 28, 2025

News Conference News ACC 2025

PCI Rebounds at 5 Years to Mostly Match CABG: Final FAME 3 Data

Caitlin E. Cox

March 31, 2025

News Daily News

Cannabis Use Again Tied to Increased CVD Risk in Young People

L.A. McKeown

March 19, 2025

News Daily News

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Michael O'Riordan

February 24, 2025

News Daily News

Young Men Who Take Steroids Have Impaired Coronary Flow, Even After Quitting

Caitlin E. Cox

December 17, 2024

Presentation TCT 2024

TCT 606: Epicardial Fat Tissue: A Potential Marker for Coronary Microvascular Dysfunction

Presenter: Waiel Abusnina

October 30, 2024

Presentation TCT 2024

TCT 605: Prevalence of Coronary Microvascular Dysfunction and Vasomotor Abnormalities in Patients With History of Coronary Revascularization

Presenter: Chaitanya Chennareddy

October 30, 2024

Presentation TCT 2024

TCT 602: Association Between the Severity of Coronary Artery Stenosis With the Minimum Responsive Dose of Intracoronary Provocation Test

Presenter: Woo Jin Ahn

October 30, 2024

Presentation TCT 2024

TCT 603: Relationship Between Epicardial Pathophysiological Disease Patterns and Microvascular Function

Presenter: Bouisset Frederic

October 30, 2024

Presentation TCT 2024

TCT 604: Evaluation of Coronary Microvascular Dysfunction in Patients With Chronic Kidney Disease Presenting With Angina With Nonobstructive Coronary Arteries

Presenter: Sant Kumar

October 30, 2024

Presentation TCT 2024

TCT 601: Use of Microbubble Contrast Agent for Invasive Doppler Coronary Microvascular Assessment

Presenter: Rahul Bahl

October 30, 2024

Presentation TCT 2024

TCT 608: Microvascular Dysfunction After Elective Percutaneous Coronary Intervention: Hemodynamic and Myocardial Relevance

Presenter: Pedro Jallad

October 30, 2024

Presentation TCT 2024

TCT 607: Variability of Coronary Flow Reserve and Microvascular Resistance

Presenter: Hayder Hashim

October 30, 2024

Presentation TCT 2024

TCT 596: Retinal Ganglion Cell Degeneration in Patients With Coronary Microvascular Dysfunction

Presenter: Kyriakos Dimitriadis

October 29, 2024

Presentation TCT 2024

TCT 597: Evaluation of Renal Functional Reserve in Patients With Coronary Microvascular Dysfunction and Preserved Renal Function

Presenter: Kyriakos Dimitriadis

October 29, 2024

Presentation TCT 2024

TCT 595: The Association of Invasive Assessment of Coronary Microvascular Dysfunction With Mortality and Major Cardiovascular Events: A Systematic Review and Meta-Analysis

Presenter: Kyriakos Dimitriadis

October 29, 2024

Presentation TCT 2024

TCT 598: Diagnostic Accuracy of Exercise Stress Tests for Detection of Coronary Microvascular Dysfunction

Presenter: Hanae Namba

October 29, 2024

Advertisement

Stress CMR Facilitates Diagnosis, Targeted Care in ANOCA: CorCMR

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

Early Coronary Function Testing Improves Quality of Life in ANOCA

PCI Rebounds at 5 Years to Mostly Match CABG: Final FAME 3 Data

Cannabis Use Again Tied to Increased CVD Risk in Young People

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Young Men Who Take Steroids Have Impaired Coronary Flow, Even After Quitting

TCT 606: Epicardial Fat Tissue: A Potential Marker for Coronary Microvascular Dysfunction

TCT 605: Prevalence of Coronary Microvascular Dysfunction and Vasomotor Abnormalities in Patients With History of Coronary Revascularization

TCT 602: Association Between the Severity of Coronary Artery Stenosis With the Minimum Responsive Dose of Intracoronary Provocation Test

TCT 603: Relationship Between Epicardial Pathophysiological Disease Patterns and Microvascular Function

TCT 604: Evaluation of Coronary Microvascular Dysfunction in Patients With Chronic Kidney Disease Presenting With Angina With Nonobstructive Coronary Arteries

TCT 601: Use of Microbubble Contrast Agent for Invasive Doppler Coronary Microvascular Assessment

TCT 608: Microvascular Dysfunction After Elective Percutaneous Coronary Intervention: Hemodynamic and Myocardial Relevance

TCT 607: Variability of Coronary Flow Reserve and Microvascular Resistance

TCT 596: Retinal Ganglion Cell Degeneration in Patients With Coronary Microvascular Dysfunction

TCT 597: Evaluation of Renal Functional Reserve in Patients With Coronary Microvascular Dysfunction and Preserved Renal Function

TCT 595: The Association of Invasive Assessment of Coronary Microvascular Dysfunction With Mortality and Major Cardiovascular Events: A Systematic Review and Meta-Analysis

TCT 598: Diagnostic Accuracy of Exercise Stress Tests for Detection of Coronary Microvascular Dysfunction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content